R&D Systems uses cookies to provide you with a great website experience. By continuing to use this website you acknowledge this and agree to our cookie policy. Learn More
Home » Resources » Protocols » Protocol for the Characterization of Human Regulatory T Cells
Protocol for the Characterization of Human Regulatory T Cells
CD4+ T cell subsets exert diverse functions due to their expression of characteristic cytokines. Regulatory T (Treg) cells constitute one subset of CD4+ effector T cells that limit the development and progression of immune responses, oppose some functions of Th17 cells, and suppress the development of autoimmunity. Treg cells are characterized by the secretion of IL-9, IL-10, IL-35, and TGF-beta 1.
The development of the Treg subset of CD4+ T cells is induced by distinct extracellular signals (e.g. IL-2 in combination with TGF-beta) and is controlled by distinct transcription factors (e.g. FoxP3). Treg cells are present in low abundance in normal human peripheral blood. In vitro differentiation of Treg cells from the larger CD4+ T cell population provides increased numbers of Treg cells to facilitate research into their functions.
Following cell differentiation, flow cytometry can be used to verify the expression of established cell surface or intracellular markers of CD4+ T cell subsets. Intracellular markers include transcription factors that control CD4+ T cell differentiation as well as signature cytokines as they traffic through secretory organelles.
Determine the percentage of differentiated cells by flow cytometry using the suggested reagents. To prepare cells for flow cytometry, wash the cells once with RPMI and resuspend them in 1 mL of RPMI, 2 mM L-glutamine, 10 units/mL penicillin, 10 µg/mL streptomycin, 10% FBS, 50 ng/mL PMA, and 1 µg/mL calcium ionomycin. Incubate the cells in a 37 °C, 5% CO2, humidified incubator for 1 hour. Then add monesin to a final concentration of 3 µM and incubate for an additional 3 hours.
Detection of FoxP3 in Human Natural Tregs by Flow Cytometry..Natural Tregs from human peripheral blood mononuclear cells (PBMC) were surface stained with (A) Fluorescein-conjugated Mouse Anti-Human CD4 Monoclonal Antibody (Catalog # FAB3791F) and (B) APC-conjugated Mouse Anti-Human CD25/IL-2 R alpha Monoclonal Antibody (Catalog # FAB1020A) followed by intracellular staining using PE-conjugated Rabbit Anti-Human/ Mouse FoxP3 Monoclonal Antibody (Catalog # IC8214P). To facilitate intracellular staining, cells were fixed and permeabilized with FlowX FoxP3 Fixation & Permeabilization Buffer Kit (Catalog # FC012).Cells were gated on lymphocytes.
The culture medium from CD4+ T cell differentiation procedures should be analyzed to confirm that the cells are secreting cytokines relevant to the desired cell subset. Multiplex detection techniques enable efficient screening for many cytokines simultaneously. Both Proteome Profiler™ Antibody Arrays and Luminex®-based Flow Cytometry Assays are optimized for maximum specificity and sensitivity of analyte detection.
Proteome Profiler™ Antibody Arrays allow for the measurement of up to 119 proteins in a single sample. These arrays require no specialized equipment and eliminate the need for multiple Western blot experiments. Antibody array kits contain buffers, detection antibodies, and membranes spotted in duplicate with high quality capture antibodies. The arrays utilize chemiluminescence for detection, and membranes can be assessed for protein levels in the same manner as traditional Western blots. Select arrays are also suitable for use with the LI-COR® detection system. Please see our website for a generalized protocol or video on how to use these antibody arrays. Detailed array-specific instructions are provided in the booklet for each array kit.
Click here for data examples of the analysis of secreted human, mouse, or rat cytokines.
Luminex Screening and Performance Assays utilize color-coded polystyrene or superparamagnetic beads coated with analyte-specific antibodies. Beads recognizing different target analytes are mixed together and incubated with the sample. Captured analytes are subsequently detected using a cocktail of biotinylated detection antibodies and a streptavidin-phycoerythrin conjugate.
Polystyrene beads are designed for use with the Luminex 100™, Luminex 200, or Bio-Rad® Bio-Plex® dual-laser analyzers. One laser in the instrument determines the color of each bead while the second laser determines the magnitude of the PE-derived signal, which is directly proportional to the amount of analyte bound.
Magnetic beads are compatible with Luminex MAGPIX®, Luminex 100™, Luminex 200, and Bio-Rad® Bio-Plex® analyzers. The Luminex MAGPIX® analyzer utilizes a magnet to hold the superparamagnetic microparticles in a monolayer while light emitting diodes illuminate and a CCD camera images each well.
Luminex Screening Assays from R&D Systems are designed to maximize multiplexing capacity and flexibility while maintaining assay specificity.
Largest Luminex Multiplex Available: simultaneously analyze up to 100 analytes
Flexible Analyte Selection: choose from over 175 analytes
Unique Analytes Offered: over 50 analytes are exclusively available from R&D Systems
Rapidly Expanding Menu: new analytes are released monthly
Polystyrene or Magnetic Options: all analytes are available in either the polystyrene or magnetic microparticle format
Luminex Performance Assays from R&D Systems are designed to maximize assay accuracy and precision while preserving the benefits of multiplexing.
Accurate and Reproducible Results: panel development and validation testing are similar to R&D Systems gold-standard Quantikine® ELISA assays
Polystyrene or Magnetic Options: select panels are available in either the polystyrene or magnetic microparticle format
User-Defined Analyte Selection: choose analytes from established panels and select “premixed” or “end-user mixed” options
User-selected combinations of analytes can be assembled with our Luminex Assay Ordering Tool. The ordering tool walks you step-by-step through choices of screening or performance assays, polystyrene or magnetic bead formats, species options, and target analytes of interest.
Our list of analytes for Screening Assays numbers more than 200 and is continuously growing. Please see our Luminex Assay Customization Tool for the current selection.
Data from the measurement of 158 analytes secreted by unstimulated and stimulated NK cells.
Figure 1. A) Heat map showing the tested biomarkers. Colors correspond to high, mid, and low abundance. B) Quantitative comparison of biomarker concentrations between stimulated and unstimulated NK cells.
Figure 2. A) Heat map showing the tested biomarkers. Colors correspond to high, mid, and low abundance. B) Quantitative comparison of biomarker concentrations between stimulated and unstimulated NK cells. *The increased IL-12 levels in stimulated cells was due to addition of IL-12 during the stimulation procedure.
Figure 3. A) Heat map showing the tested biomarkers. Colors correspond to high, mid, and low abundance. B) Quantitative comparison of biomarker concentrations between stimulated and unstimulated NK cells.
R&D Systems offers a wide variety of sandwich ELISA kits that are designed to provide high levels of specificity, accuracy, precision, and sensitivity in analyte quantification. They are available in a range of formats including colorimetric, fluorescence, and chemiluminescence-based kits for measuring intracellular and extracellular proteins.
Quantikine® ELISA kits have been exhaustively tested for superior quality and reproducibility. Kit performance relies heavily on the selection of high quality antibody pairs and rigorous in-house testing throughout the development process. This includes component and kit stability, sensitivity, linearity, recovery, intra- and inter-assay precision, as well as cross-reactivity and interference testing with related an¬alytes to confirm assay specificity. This stringent validation testing is used to optimize assay per¬formance and verify that each kit will provide reproducible results both well-to-well and lot-to-lot.
DuoSet® ELISA Development Systems contain the basic components required to develop an immunoassay. They offer an economical alternative to buying separate antibodies and proteins.